Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation
Conditions
- MSS
- RAS-mutant Colorectal Cancer
Interventions
- DRUG: binimetinib
- DRUG: nivolumab
- DRUG: ipilimumab
Sponsor
Pfizer
Collaborators